Qualcomm Incorporated (NASDAQ:QCOM - Get Free Report) was the recipient of some unusual options trading activity on Friday. Stock traders purchased 302,615 call options on the stock. This represents an increase of 203% compared to the average daily volume of 99,719 call options. Get Qualcomm alerts: Sign Up Qualcomm News Roundup Here are the key news stories impacting Qualcomm this week: Insider B...
Qualcomm Incorporated (NASDAQ:QCOM - Get Free Report) was the recipient of some unusual options trading activity on Friday. Stock traders purchased 302,615 call options on the stock. This represents an increase of 203% compared to the average daily volume of 99,719 call options. Get Qualcomm alerts: Sign Up Qualcomm News Roundup Here are the key news stories impacting Qualcomm this week: Insider Buying and Selling at Qualcomm In other news, EVP Akash J. Palkhiwala sold 2,500 shares of Qualcomm stock in a transaction that occurred on Monday, April 13th. The shares were sold at an average price of $130.34, for a total transaction of $325,850.00. Following the completion of the transaction, the executive vice president directly owned 30,684 shares in the company, valued at approximately $3,999,352.56. This trade represents a 7.53% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Patricia Y. Grech sold 829 shares of Qualcomm stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $201.77, for a total transaction of $167,267.33. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 19,306 shares of company stock valued at $3,435,583 over the last ninety days. Company insiders own 0.05% of the company's stock. Institutional Investors Weigh In On Qualcomm A number of large investors have recently added to or reduced their stakes in the stock. Norges Bank purchased a new position in shares of Qualcomm during the 4th quarter worth $2,591,056,000. Wellington Management Group LLP boosted its stake in shares of Qualcomm by 141.8% during the 3rd quarter. Wellington Management Group LL...
Biopharmaceutical stocks require time and patience. But when the company gets it right, investors get rewarded as they have with Kiniksa Pharmaceuticals NASDAQ: KNSA. The stock is up over 100% in the last year. Much of that growth came after the company’s strong Q1 earnings report on April 28, in which it topped adjusted earnings per share (EPS) estimates by 9 cents, coming in at 27 cents. Kiniksa...
Biopharmaceutical stocks require time and patience. But when the company gets it right, investors get rewarded as they have with Kiniksa Pharmaceuticals NASDAQ: KNSA. The stock is up over 100% in the last year. Much of that growth came after the company’s strong Q1 earnings report on April 28, in which it topped adjusted earnings per share (EPS) estimates by 9 cents, coming in at 27 cents. Kiniksa Pharmaceuticals International Today KNSA Kiniksa Pharmaceuticals International $53.24 -0.41 (-0.76%) 52-Week Range $25.70 ▼ $59.87 P/E Ratio 59.16 Price Target $60.86 Add to Watchlist At that time, the company announced the launch of a targeted direct-to-consumer TV campaign for ARCALYST in recurrent pericarditis. ARCALYST is the first and only U.S. Food & Drug Administration (FDA) approved therapy for recurrent pericarditis. It received this designation in 2021. Get KNSA alerts: Sign Up After some initial volatility, ARCALYST saw revenue of about $48 million in March 2023. Revenue growth has accelerated, reaching a new record of $214.27 million in Q1 2026, a 56% year-over-year (YOY) gain. The new campaign is significant because it shows that Kiniksa is investing in demand generation at scale rather than relying solely on prescriber growth. To that end, the company raised its full-year revenue guidance to $930 million to $945 million. The prior guidance was for a range between $900 million and $920 million. A Singular Focus Moving Into Its Second Generation Like many biotech companies, Kiniska focuses on discovering and advancing novel, transformative therapies for patients with unmet medical needs. The company’s specific focus is on cardiovascular diseases, specifically pericarditis. Pericarditis is an inflammation of the pericardium—the thin, fluid-filled sac surrounding the heart—that causes sharp chest pain, fatigue, and in severe cases, dangerous fluid buildup around the heart. When the condition keeps coming back despite standard anti-inflammatory treatments like NSA...
US Secretary of State Marco Rubio will meet Indian Prime Minister Narendra Modi on Saturday, with energy security high on the agenda as the South Asian nation grapples with soaring oil prices and supply disruptions stemming from the war in Iran. Ahead of the visit, Rubio said Washington was prepared to supply more energy to the world’s most-populous nation as India looks to diversify imports after...
US Secretary of State Marco Rubio will meet Indian Prime Minister Narendra Modi on Saturday, with energy security high on the agenda as the South Asian nation grapples with soaring oil prices and supply disruptions stemming from the war in Iran. Ahead of the visit, Rubio said Washington was prepared to supply more energy to the world’s most-populous nation as India looks to diversify imports after the Middle East conflict disrupted global flows. India has been hit hard because of its heavy reliance on energy supplies shipped through the Strait of Hormuz, a key waterway effectively blocked soon after Iran was attacked late February. As surging oil prices batter the rupee and trigger record foreign outflows from local equities, the government this month rushed to introduce measures to contain the fallout, including raising fuel prices. India has also ramped up purchases of Russian oil during the conflict, after briefly pulling back last year under pressure from Washington. “Energy will be main focus of the bilateral agenda,” said Pramit Pal Chaudhuri, South Asia practice head for the Eurasia Group. “Defense and technology will be discussed but major announcements are unlikely.” New Delhi is set to import record amounts of liquefied petroleum gas and liquefied natural gas from the US in May, according to predictive data from Kpler, underscoring the importance of the US to India’s energy security. Before the war, India relied heavily on the Strait of Hormuz for LPG shipments used as cooking fuel, with about 90% of its imports passing through the waterway. During his visit, Rubio will also take part on Tuesday in a meeting of the Quad, a strategic grouping of the US, India, Japan and Australia. The partnership focuses on promoting a free and inclusive Indo-Pacific and is widely viewed as a counterweight to China’s growing economic and military influence in the region. The trip comes at a time when India and the US are still working to repair frayed ties. Last May, Trump ...
AlexSecret/iStock via Getty Images Bond volatility remains Global equity markets moved modestly higher this week as first-quarter earnings season continued to deliver strong results. With Nvidia ( NVDA ) reporting this week, the U.S. earnings season is now nearing completion. Overall, earnings growth for the S&P 500 is tracking above 20% year-over-year, reflecting a particularly strong reporting p...
AlexSecret/iStock via Getty Images Bond volatility remains Global equity markets moved modestly higher this week as first-quarter earnings season continued to deliver strong results. With Nvidia ( NVDA ) reporting this week, the U.S. earnings season is now nearing completion. Overall, earnings growth for the S&P 500 is tracking above 20% year-over-year, reflecting a particularly strong reporting period. Management guidance has also remained constructive, especially across technology and commodity-linked sectors. This has helped support further upgrades to analyst earnings expectations. Through Thursday’s close: · The S&P 500 Index gained roughly 0.5% on the week · The MSCI All Country World Index rose around 1% · The MSCI Emerging Markets Index advanced approximately 1.5% The broad-based nature of these gains suggests that healthy earnings growth continues to provide an important foundation for equity markets. U.S. economy shows resilience as Europe slows This week’s economic data painted a mixed global picture. In the United States, recent data continued to point toward resilience despite ongoing geopolitical uncertainty and elevated energy prices. May purchasing managers’ indices showed notable strength in manufacturing activity, which reached its highest level in nearly four years. Fiscal stimulus measures introduced last year, along with continued AI-related investment, appear to be supporting industrial activity. The U.S. consumer also remains engaged. Labor market data, including weekly ADP employment figures and initial jobless claims, continues to point to stable hiring conditions and a relatively healthy labor market. Outside the U.S., however, growth signals were softer. In both the eurozone and the UK, purchasing managers’ indices fell below the 50 threshold in May, suggesting that growth may be stalling. Economies more exposed to higher energy prices and commodity supply disruptions appear increasingly vulnerable as the Middle East conflict continues. Th...
The first-quarter Form 13F that Bill Ackman's Pershing Square Capital Management filed recently revealed a notable portfolio shift that has attracted some attention from retail and institutional investors alike. The billionaire activist investor sold nearly all of his fund's $1.9 billion or so stake in Alphabet (GOOGL 1.19%) (GOOG 1.04%) and redirected the proceeds into a new position in Microsoft...
The first-quarter Form 13F that Bill Ackman's Pershing Square Capital Management filed recently revealed a notable portfolio shift that has attracted some attention from retail and institutional investors alike. The billionaire activist investor sold nearly all of his fund's $1.9 billion or so stake in Alphabet (GOOGL 1.19%) (GOOG 1.04%) and redirected the proceeds into a new position in Microsoft (MSFT 0.06%). This move reflected Ackman's investment philosophy -- patient ownership of high-quality compounders bought at reasonable prices, followed by decisive profit-taking when better risk-reward setups form elsewhere. When did Pershing Square invest in Alphabet? Pershing Square initiated its position in Alphabet in early 2023, acquiring 2.2 million Class A shares and 8.1 million Class C shares. Back then, Alphabet traded between $90 and $100 per share. At the time, the stock appeared undervalued relative to its dominant position in search, its budding cloud business, and its emerging capabilities in artificial intelligence (AI). Pershing Square's Alphabet stake eventually grew into one of its largest holdings. Ackman held onto the position through Alphabet's AI-driven rally, watching shares more than triple as the company's advertising engine remained resilient and its investments in YouTube, Google Cloud, and generative AI began to bear fruit. During the second half of 2025, Pershing Square modestly trimmed its stake as Alphabet witnessed substantial valuation expansion. During the first quarter of 2026, Ackman reduced his fund's exposure to Alphabet by 95% across both share classes. Ackman took to social media to explain that the Alphabet sale was not a bearish call on the company's long-term prospects. In fact, he remains bullish on Alphabet's competitive moat. The exit merely represented a classic demonstration of prudent portfolio management. After years of strong performance and a significant run-up, Alphabet stock no longer offered the same margin of safety i...